AshHill Biomedical Investments

About The Fund

AshHill Biomedical Investments is a private equity fund based in Bethesda, Maryland, United States, with profound expertise in equity investments. They concentrate on seed, startup, and early-stage funding within the Medical Devices & Hospital Services, and Life Science sectors. Positioning themselves as integral partners to groundbreaking healthcare and business services companies, AshHill Biomedical Investments leverages its deep vertical expertise to invest in niche leaders of the lower middle market. They have a long-standing investment history since 2003, with over 100 investments and $1.8 billion invested over the span of more than 20 years. AshHill's team is cohesive and dedicated, having worked together to pursue a consistent strategy with a focus on health care and business services companies. By maintaining a strong network of relationships with executives across various sub-verticals, the firm has developed a remarkable level of familiarity with many competitors in these sectors, establishing themselves as not just investors, but also as stewards of the companies they support. AshHill is committed to partnering with companies to enhance growth strategies through methods like mergers and acquisitions, creating de novo service lines, and expanding customer bases, all while preserving company culture and ensuring customer satisfaction. Their portfolio includes a diverse range of companies from different healthcare and business services subsectors, such as healthcare cost containment solutions, behavioral health organizations, niche contract research organizations, cloud-based educational solutions, and more. AshHill Biomedical Investments actively seeks out the addition of companies that are aligned with its strategic focus to its portfolio, and it incorporates environmental, social, and governance policies as well as diversity, equity, and inclusion initiatives into its work philosophy, thereby investing with care and purpose.